Andere Sprachen Bide Pharmatech Co., Ltd.

Aktien

688073

CNE100005NV3

688073

Biotechnologie

Schlusskurs Shanghai S.E. Andere Börsenplätze 12.12.2025			% 5 Tage	Veränd. 1. Jan.
67,49 ^CNY	+0,73 %		-2,29 %	+37,29 %

29.10.	Bide Pharmatech Co., Ltd. meldet Geschäftsergebnisse für die ersten neun Monate bis zum 30. September 2025	CI
08.09.	Bide Pharmatech-Aktionäre kündigen Anteilsreduzierung an	MT

Andere Sprachen

Bide Pharmatech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	29.10.
Certain A Shares of Bide Pharmatech Co., Ltd. are subject to a Lock-Up Agreement Ending on 11-OCT-2025.	11.10.
Bide Pharmatech Shareholders to Reduce Stakes	08.09.
Shanghai Market Regulators Approve Bide Pharmatech's Changes to Business License	03.09.
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	21.08.
Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on February 8, 2025.	31.07.
Bide Pharmatech Co., Ltd.'s Equity Buyback announced on February 8, 2025, has closed with 2,176,148 shares, representing 2.48% for CNY 99.99 million.	30.07.
Bide Pharmatech Co., Ltd. announces Annual dividend, payable on June 09, 2025	24.04.
Bide Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	23.04.
Bide Pharmatech Co., Ltd. cancelled the transaction announced on January 21, 2025	14.04.
Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on February 8, 2025.	02.04.
Bide Pharmatech Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	08.02.
Bide Pharmatech Co., Ltd. authorizes a Buyback Plan.	07.02.
Bide Pharmatech to Issue Share to Acquire Assets	05.02.
Bide Pharmatech Co., Ltd. announced a financing transaction	21.01.
Bide Pharmatech Co., Ltd. agreed to acquire an unknown minority stake in Zhuhai Weibo Investment Co., Ltd. from Vivo Health Industry Investment Fund (Limited Partnership) managed by Vivo Capital, LLC and Vivo Equity Investment Management Co. Ltd.	21.01.
Bide Pharmatech Investing $103 Million in Zhuhai Vivo Investment JV	14.01.
Zhuhai Weibo Investment Co., Ltd. announced that it expects to receive funding from Bide Pharmatech Co., Ltd., Vivo Capital, LLC, Vivo Equity Investment Management Co. Ltd., Vivo Cypress X, Co. Limited	13.01.
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	23.10.24
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	28.08.24
Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.	09.07.24
Bide Pharmatech Co., Ltd.'s Equity Buyback announced on December 9, 2023, has closed with 2,554,024 shares, representing 2.82% for CNY 99.99 million.	05.07.24
Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.	03.07.24
Bide Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25.04.24
Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.	02.04.24

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bide Pharmatech Co., Ltd.

Aktien

688073

CNE100005NV3

688073

Biotechnologie

Andere Sprachen

Filter